Tuesday, Jun 28, 2022
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Granules India Q4 Net Profit Up 38 Per Cent
Ads

Granules India Q4 net profit up 38 per cent

By PTI
Published: Published Date - 12:07 AM, Wed - 12 May 21
Consolidated revenue from operations of the company stood at Rs 799 crore for the quarter under consideration

New Delhi: Drug firm Granules India on Tuesday reported a 38.15 percent rise in its consolidated net profit to Rs 127.56 crore for the quarter ended March 31, 2021, on account of robust sales. The company had posted a net profit of Rs 92.33 crore for the corresponding period of the previous fiscal, Granules India said in a regulator filing.

Consolidated revenue from operations of the company stood at Rs 799 crore for the quarter under consideration. It was Rs 600 crore for the same period a year ago, it added. For the financial year ended March this year, the company posted a net profit of Rs 549 crore as against Rs 335 crore for the previous financial year, Granules India said.

The company’s revenue from operations of the company stood at Rs 3,238 crore for the financial year under consideration. It was at Rs 2,599 crore for the previous financial year, it added. “Despite unprecedented challenges over the past year, our robust performance demonstrates the unwavering commitment of our colleagues and the resilience of our business. We are investing for the next phase of growth across all verticals,” Granules India CMD Krishna Prasad Chigurupati said.

The board of directors has recommended a final dividend of 75 paise per equity share of Re1 each in addition to an interim dividend of 75 paise per equity share of Re 1 each paid during the year, the filing said. Shares of Granules India Ltd closed at Rs 359.90 per scrip on the BSE, down 1.17 percent from its previous close.

  • Follow Us :
  • Tags
  • Drug firm
  • Granules India CMD
  • Granules. India
  • Krishna Prasad Chigurupati

Related News

  • ONGC to see $3 bn rise in earnings, Reliance $1.5 bn from gas price hike

  • Andhra Pradesh seeks ways to boost revenue

  • GST revenue at over Rs 1.16 lakh cr in July

  • Granules concludes Covid-19 vaccine drive for its workforce

  • India Inc Q1 revenues falling 8-10pc sequentially: Report

  • Granules India earmarks capex of Rs 1,000 cr

Latest News

  • 40 people found dead inside tractor-trailer in Texas

    17 mins ago
  • After multiple surgeries, this minor rape victim is finally smiling

    25 mins ago
  • Google to shut down Hangouts, tell users to switch to Chat

    31 mins ago
  • 12 killed, 251 injured in toxic gas leak at Jordan port

    35 mins ago
  • Tesla workers find lack of seats, crappy Wi-Fi as they return to office: Report

    43 mins ago
  • Instagram and Facebook remove posts offering abortion pills

    46 mins ago
  • About 200 brands register for EPR ahead of Single Use Plastic ban

    1 hour ago
  • UP Police books RGV over controversial tweet on Draupadi Murmu

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam